O
OrbiMed’s RAPT Therapeutics RAPT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.1M | Sell |
1,641,906
-11,493,354
| -88% | -$91.9M | 0.33% | 51 |
|
2025
Q1 | $16M | Hold |
13,135,260
| – | – | 0.38% | 49 |
|
2024
Q4 | $20.8M | Buy |
+13,135,260
| New | +$20.8M | 0.43% | 53 |
|
2024
Q1 | – | Sell |
-281,413
| Closed | -$6.99M | – | 122 |
|
2023
Q4 | $6.99M | Sell |
281,413
-963,532
| -77% | -$23.9M | 0.14% | 84 |
|
2023
Q3 | $20.7M | Sell |
1,244,945
-6,125
| -0.5% | -$102K | 0.44% | 63 |
|
2023
Q2 | $23.4M | Hold |
1,251,070
| – | – | 0.42% | 66 |
|
2023
Q1 | $23M | Hold |
1,251,070
| – | – | 0.45% | 62 |
|
2022
Q4 | $24.8M | Hold |
1,251,070
| – | – | 0.47% | 61 |
|
2022
Q3 | $30.1K | Buy |
1,251,070
+384,674
| +44% | +$9.26K | 0.56% | 58 |
|
2022
Q2 | $15.8K | Buy |
866,396
+505,096
| +140% | +$9.22K | 0.29% | 73 |
|
2022
Q1 | $7.95M | Buy |
361,300
+144,300
| +66% | +$3.17M | 0.13% | 108 |
|
2021
Q4 | $7.97M | Buy |
+217,000
| New | +$7.97M | 0.1% | 121 |
|